☆ 4.8 Article

Functional Activity of the Complement System in Hospitalized COVID-19 Patients: A Prospective Cohort Study

FRONTIERS IN IMMUNOLOGY (2021)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Immunology

Complement Activation in the Disease Course of Coronavirus Disease 2019 and Its Effects on Clinical Outcomes

Aline H. de Nooijer et al.

Summary: In COVID-19 patients, activation of the complement system is associated with disease severity, mortality rate, and thromboembolic events. This suggests components of the complement system could serve as potential prognostic markers and therapeutic targets in COVID-19.

JOURNAL OF INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Medicine, Research & Experimental

Evaluation of the efficacy and safety of icatibant and C1 esterase/kallikrein inhibitor in severe COVID-19: study protocol for a three-armed randomized controlled trial

Eli Mansour et al.

Summary: This study aims to explore the mechanism of increased bradykinin in the lungs of COVID-19 patients in developing pneumonia and respiratory failure, with three arms of randomized clinical trial designed for different treatment regimens. The results of the study may help alleviate lung inflammatory response in severe COVID-19 patients, positively impacting disease severity and mortality rates.

TRIALS (2021)

添加到收藏夹

Letter Medicine, Research & Experimental

Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19)

Pascal Urwyler et al.

Summary: The study aims to investigate the efficacy and safety of conestat alfa in COVID-19 patients with pulmonary disease. It is an investigator-initiated, multicenter randomized controlled trial.

TRIALS (2021)

添加到收藏夹

Article Medicine, General & Internal

Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19

Anthony C. Gordon et al.

Summary: Interleukin-6 receptor antagonists tocilizumab and sarilumab were found to improve outcomes, including survival, in critically ill patients with Covid-19 receiving organ support in ICUs according to an ongoing international trial. The efficacy of these treatments has been confirmed, with patients benefiting from the therapy.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Biology

SARS-CoV-2 suppresses anticoagulant and fibrinolytic gene expression in the lung

Alan E. Mast et al.

Summary: In COVID-19 patients, extensive fibrin deposition in the lungs and altered levels of circulating blood coagulation proteins suggest impaired local pathways that limit fibrin formation and promote clearance. Analysis of bronchoalveolar lavage fluid samples revealed decreased transcriptional levels related to fibrinolysis and increased levels related to coagulation, indicating enhanced coagulation propagation and reduced fibrinolysis as drivers of lung coagulopathy in COVID-19 patients.

ELIFE (2021)

添加到收藏夹

Article Neurosciences

Complement Activation in the Central Nervous System: A Biophysical Model for Immune Dysregulation in the Disease State

Nicholas Peoples et al.

Summary: This article discusses the importance of regulating complement in the nervous system and suggests that dysregulation may lead to neurological diseases, calling for research into the mechanisms of dysregulation through biophysical and chemical principles. Additionally, it describes the potential effects of complement dysregulation on central nervous system diseases, particularly Alzheimer's Disease, and how these concepts provide new research avenues for neurodegenerative processes.

FRONTIERS IN MOLECULAR NEUROSCIENCE (2021)

添加到收藏夹

Article Infectious Diseases

Mannose binding lectin gene 2 (rs1800450) missense variant may contribute to development and severity of COVID-19 infection

Alpay Medetalibeyoglu et al.

Summary: The study investigated the impact of the MBL2 gene B variant on COVID-19 patients. Results showed that patients with the BB or AB genotypes were more likely to develop severe illness and require ICU treatment. However, there was no significant difference in terms of mortality rate or secondary bacterial infections.

INFECTION GENETICS AND EVOLUTION (2021)

添加到收藏夹

Article Virology

Complement levels at admission as a reflection of coronavirus disease 2019 (COVID-19) severity state

Brandon Michael Henry et al.

Summary: Complement system hyperactivation in COVID-19 patients is associated with hyperinflammation and thrombotic microangiopathy, but failed to accurately predict disease severity. Complement inhibition should be further investigated for potential benefit in patients with hyperinflammatory and microangiopathic phenotype.

JOURNAL OF MEDICAL VIROLOGY (2021)

添加到收藏夹

Article Medicine, General & Internal

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani et al.

LANCET (2021)

添加到收藏夹

Article Medical Laboratory Technology

The role of the lectin pathway of the complement system in SARS-CoV-2 lung injury

Mineia Alessandra Scaranello Malaquias et al.

Summary: This study aimed to investigate the role of MBL and ficolin-3 in the complement system activation in COVID-19 patients compared to H1N1 infection and control groups. The findings showed higher tissue expression of proinflammatory cytokines in COVID-19 patients, with particular emphasis on MBL and FCN3. Additionally, certain genetic polymorphisms were associated with high MBL tissue expression in COVID-19 pulmonary samples.

TRANSLATIONAL RESEARCH (2021)

添加到收藏夹

Article Immunology

Complement Overactivation and Consumption Predicts In-Hospital Mortality in SARS-CoV-2 Infection

Gyorgy Sinkovits et al.

Summary: Uncontrolled complement activation is associated with advanced disease severity of COVID-19, with patients more likely to die when accompanied by overactivation and consumption of C3. These findings support the potential use of complement inhibitory drugs in the treatment of COVID-19.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Article Immunology

Plasma Lectin Pathway Complement Proteins in Patients With COVID-19 and Renal Disease

Nicholas R. Medjeral-Thomas et al.

Summary: This study investigated the increased susceptibility of non-white ethnicity and chronic kidney disease to COVID-19, finding that lectin pathway activation may influence the severity of the disease. Unique associations between recognition molecules of the lectin pathway and COVID-19, including severity, were identified in patients of Asian and White ethnicity.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Article Medicine, General & Internal

Defective NET clearance contributes to sustained FXII activation in COVID-19-associated pulmonary thrombo-inflammation

Hanna Englert et al.

Summary: The study shows that increased expression and activity of FXII are found in lung tissues of COVID-19 patients, and NET accumulation leads to FXII contact activation. Additionally, insufficient DNase contributes to NETs accumulation, exacerbating FXII activation.

EBIOMEDICINE (2021)

添加到收藏夹

Article Immunology

Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection

Lina Ma et al.

Summary: Complement activation is elevated in patients with COVID-19 and is associated with severe illness, endothelial injury, and hypercoagulability, serving as a distinctive feature of COVID-19 and providing specific targets for risk prognostication and drug discovery.

SCIENCE IMMUNOLOGY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

SARS-CoV-2 RNAemia and proteomic trajectories inform prognostication in COVID-19 patients admitted to intensive care

Clemens Gutmann et al.

Summary: Prognostic characteristics for ICU COVID-19 patients can be determined using blood samples, with RNAemia and pentraxin-3 identified as predictors of 28-day ICU mortality. Additionally, galectin-3-binding protein is found to interact with the SARS-CoV-2 spike glycoprotein and exhibit antiviral properties.

NATURE COMMUNICATIONS (2021)

添加到收藏夹

Article Immunology

Transcriptomic Signature Differences Between SARS-CoV-2 and Influenza Virus Infected Patients

Stephanie Bibert et al.

Summary: The dysregulated immunity in COVID-19 patients plays a key role in the severity of the disease, including defects in IFN responses, reduced toxicity-related molecules in NK cells, and increased neutrophil degranulation. Additionally, differences in gene expression patterns are also determinants of COVID-19 severity.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Article Immunology

Lectin Pathway Mediates Complement Activation by SARS-CoV-2 Proteins

Youssif M. Ali et al.

Summary: Early and persistent complement activation is crucial in the pathogenesis of COVID-19, leading to a series of pathological events that trigger severe inflammatory responses to SARS-CoV-2. Research targeting MASP-2 suggests that the LP pathway of the complement system could offer a therapeutic window for treating severe COVID-19.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Article Medicine, General & Internal

Temporal trends of COVID-19 related in-hospital mortality and demographics in Switzerland - a retrospective single centre cohort study

Diebold Matthias et al.

Summary: The study conducted in a hospital in Switzerland showed that the in-hospital mortality of COVID-19 patients is influenced by factors such as age, male gender, immunocompromising condition, and chronic kidney disease. Patients without comorbidities have a very low in-hospital mortality rate regardless of age.

SWISS MEDICAL WEEKLY (2021)

添加到收藏夹

Article Critical Care Medicine

Increased Alternative Complement Pathway Function and Improved Survival during Critical Illness

William Bain et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Proteomic and Metabolomic Characterization of COVID-19 Patient Sera

Bo Shen et al.

CELL (2020)

添加到收藏夹

Article Immunology

Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China

Chuan Qin et al.

CLINICAL INFECTIOUS DISEASES (2020)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Well-aerated Lung on Admitting Chest CT to Predict Adverse Outcome in COVID-19 Pneumonia

Davide Colombi et al.

RADIOLOGY (2020)

添加到收藏夹

Article Medical Laboratory Technology

Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases

Cynthia Magro et al.

TRANSLATIONAL RESEARCH (2020)

添加到收藏夹

Article Hematology

Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition

Jia Yu et al.

BLOOD (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection

Vijendra Ramlall et al.

NATURE MEDICINE (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients

Jan C. Holter et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

添加到收藏夹

Article Hematology

Mannose-Binding Lectin is Associated with Thrombosis and Coagulopathy in Critically Ill COVID-19 Patients

Oskar Eriksson et al.

THROMBOSIS AND HAEMOSTASIS (2020)

添加到收藏夹

Article Immunology

Local and Systemic Concentrations of Pattern Recognition Receptors of the Lectin Pathway of Complement in a Cohort of Patients With Interstitial Lung Diseases

Severin Vogt et al.

FRONTIERS IN IMMUNOLOGY (2020)

添加到收藏夹

Article Immunology

Treatment of COVID-19 With Conestat Alfa, a Regulator of the Complement, Contact Activation and Kallikrein-Kinin System

Pascal Urwyler et al.

FRONTIERS IN IMMUNOLOGY (2020)

添加到收藏夹

Article Microbiology

Herpes simplex encephalitis in adult patients with MASP-2 deficiency

Stephanie Bibert et al.

PLOS PATHOGENS (2019)

添加到收藏夹

Review Immunology

C-Type Lectin Receptors in Antiviral Immunity and Viral Escape

Marta Bermejo-Jambrina et al.

FRONTIERS IN IMMUNOLOGY (2018)

添加到收藏夹

Review Immunology

The Lectin Pathway of Complement in Myocardial ischemia/Reperfusion injury-Review of its Significance and the Potential impact of Therapeutic interference by C1 esterase inhibitor

Anneza Panagiotou et al.

FRONTIERS IN IMMUNOLOGY (2018)

添加到收藏夹

Article Immunology

Active Human Complement Reduces the Zika Virus Load via Formation of the Membrane-Attack Complex

Britta Schiela et al.

FRONTIERS IN IMMUNOLOGY (2018)

添加到收藏夹

Article Biochemistry & Molecular Biology

Collectins, H-ficolin and LL-37 reduce influence viral replication in human monocytes and modulate virus-induced cytokine production

Mitchell R. White et al.

INNATE IMMUNITY (2017)

添加到收藏夹

Article Infectious Diseases

Functional polymorphisms of the CCL2 and MBL genes cumulatively increase susceptibility to severe acute respiratory syndrome coronavirus infection

Xinyi Tu et al.

JOURNAL OF INFECTION (2015)

添加到收藏夹

Review Biochemistry & Molecular Biology

Toward a structure-based comprehension of the lectin pathway of complement

Troels R. Kjaer et al.

MOLECULAR IMMUNOLOGY (2013)

添加到收藏夹

Article Critical Care Medicine

C1-esterase inhibitor infusion increases survival rates for patients with sepsis

Anton A. Igonin et al.

CRITICAL CARE MEDICINE (2012)

添加到收藏夹

Article Immunology

Human H-Ficolin Inhibits Replication of Seasonal and Pandemic Influenza A Viruses

Anamika Verma et al.

JOURNAL OF IMMUNOLOGY (2012)

添加到收藏夹

Review Immunology

The Genetics of Ficolins

Peter Garred et al.

JOURNAL OF INNATE IMMUNITY (2010)

添加到收藏夹

Article Virology

A Single Asparagine-Linked Glycosylation Site of the Severe Acute Respiratory Syndrome Coronavirus Spike Glycoprotein Facilitates Inhibition by Mannose-Binding Lectin through Multiple Mechanisms

Yanchen Zhou et al.

JOURNAL OF VIROLOGY (2010)

添加到收藏夹

Article Infectious Diseases

Lack of association between polymorphisms of MASP2 and susceptibility to SARS coronavirus infection

Yan Wang et al.

BMC INFECTIOUS DISEASES (2009)

添加到收藏夹

Article Biochemistry & Molecular Biology

Comparative study of the human ficolins reveals unique features of Ficolin-3 (Hakata antigen)

Tina Hummelshoj et al.

MOLECULAR IMMUNOLOGY (2008)

添加到收藏夹

Review Biochemistry & Molecular Biology

C1, MBL-MASPs and C1-inhibitor: novel approaches for targeting complement-mediated inflammation

Laszlo Beinrohr et al.

TRENDS IN MOLECULAR MEDICINE (2008)

添加到收藏夹

Review Genetics & Heredity

Mannose-binding lectin and its genetic variants

P Garred et al.

GENES AND IMMUNITY (2006)

添加到收藏夹

Article Immunology

Association between mannose-binding lectin gene polymorphisms and susceptibility to severe acute respiratory syndrome coronavirus infection

HX Zhang et al.

JOURNAL OF INFECTIOUS DISEASES (2005)

添加到收藏夹

Article Immunology

Mannose-binding lectin in severe acute respiratory syndrome coronavirus infection

WKE Ip et al.

JOURNAL OF INFECTIOUS DISEASES (2005)

添加到收藏夹

Article Immunology

Interaction of C1q and mannan-binding lectin with viruses

NM Thielens et al.

IMMUNOBIOLOGY (2002)

添加到收藏夹

Review Medicine, General & Internal

Advances in immunology: Complement (Second of two parts).

MJ Walport

NEW ENGLAND JOURNAL OF MEDICINE (2001)

添加到收藏夹

Review Medicine, General & Internal

Advances in immunology: Complement (First of two parts).

MJ Walport

NEW ENGLAND JOURNAL OF MEDICINE (2001)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.